This page shows the publications co-authored by Hicham Skali and Michael Osborne.
Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation. J Nucl Cardiol. 2017 02; 24(1):86-99.
Reduction in ¹8F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol. 2014 Feb; 21(1):166-74.
Role of Exercise Treadmill Testing in the Assessment of Coronary Microvascular Disease. JACC Cardiovasc Imaging. 2021 Aug 11.
Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment. Circulation. 2020 01 07; 141(1):21-33.
Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT. Radiology. 2019 05; 291(2):330-337.
Erratum to: Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018 Aug; 25(4):1147.
Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018 08; 25(4):1136-1146.
Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014 Feb 04; 63(4):329-36.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.